Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Janssen’s UNIFI trial of Stelara meets primary endpoint

Janssen focuses on the development of a variety of medicines across multiple therapeutic areas. Credit: © Janssen Global Services, LLC.



  • Tonix beings enrolment in Tonmya’s RECOVERY trial for PTSD

Go Top